Cargando…

Cell Proliferation in Neuroblastoma

Neuroblastoma, the most common extracranial solid tumor of childhood, continues to carry a dismal prognosis for children diagnosed with advanced stage or relapsed disease. This review focuses upon factors responsible for cell proliferation in neuroblastoma including transcription factors, kinases, a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stafman, Laura L., Beierle, Elizabeth A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728460/ https://www.ncbi.nlm.nih.gov/pubmed/26771642 http://dx.doi.org/10.3390/cancers8010013

Ejemplares similares

EZH2 inhibition decreases neuroblastoma proliferation and in vivo tumor growth
por: Bownes, Laura V., et al.
Publicado: (2021)

Artificial Tumor Microenvironments in Neuroblastoma
por: Quinn, Colin H., et al.
Publicado: (2021)

Investigation of PP2A and Its Endogenous Inhibitors in Neuroblastoma Cell Survival and Tumor Growth
por: Williams, Adele P., et al.
Publicado: (2018)

Cancer Stem Cells and Their Interaction with the Tumor Microenvironment in Neuroblastoma
por: Garner, Evan F., et al.
Publicado: (2015)

The Role of PIM Kinases in Pediatric Solid Tumors
por: Julson, Janet Rae, et al.
Publicado: (2022)

9-cis-UAB30, a novel rexinoid agonist, decreases tumorigenicity and cancer cell stemness of human neuroblastoma patient-derived xenografts
por: Marayati, Raoud, et al.
Publicado: (2020)

Focal Adhesion Kinase Inhibition Contributes to Tumor Cell Survival and Motility in Neuroblastoma Patient-Derived Xenografts
por: Stafman, Laura L., et al.
Publicado: (2019)

PP2A activation alone and in combination with cisplatin decreases cell growth and tumor formation in human HuH6 hepatoblastoma cells
por: Stafman, Laura L., et al.
Publicado: (2019)

Targeting Focal Adhesion Kinase Suppresses the Malignant Phenotype in Rhabdomyosarcoma Cells()
por: Waters, Alicia M., et al.
Publicado: (2016)

Targeting PIM Kinases Affects Maintenance of CD133 Tumor Cell Population in Hepatoblastoma()()
por: Stafman, Laura L., et al.
Publicado: (2018)

Targeting High-Risk Neuroblastoma Patient-Derived Xenografts with Oncolytic Virotherapy
por: Quinn, Colin H., et al.
Publicado: (2022)

Pre-Clinical Study Evaluating Novel Protein Phosphatase 2A Activators as Therapeutics for Neuroblastoma
por: Bownes, Laura V., et al.
Publicado: (2022)

CRISPR/Cas9-mediated knockout of PIM3 suppresses tumorigenesis and cancer cell stemness in human hepatoblastoma cells
por: Marayati, Raoud, et al.
Publicado: (2022)

FTY720 Decreases Tumorigenesis in Group 3 Medulloblastoma Patient-Derived Xenografts
por: Garner, Evan F., et al.
Publicado: (2018)

Targeting PIM kinase as a therapeutic strategy in human hepatoblastoma
por: Stafman, Laura L., et al.
Publicado: (2018)

miR-181c expression in neuroblastoma children and proliferation of neuroblastoma M17 cells
por: Xu, Xueyan, et al.
Publicado: (2019)

Preclinical Evaluation of Engineered Oncolytic Herpes Simplex Virus for the Treatment of Neuroblastoma
por: Gillory, Lauren A., et al.
Publicado: (2013)

Serine-Threonine Kinase Receptor-Associated Protein (STRAP) Knockout Decreases the Malignant Phenotype in Neuroblastoma Cell Lines
por: Bownes, Laura V, et al.
Publicado: (2021)

UAB30, A Novel Rexinoid Agonist, Decreases Stemness In Group 3 Medulloblastoma Human Cell Line Xenografts
por: Williams, Adele P., et al.
Publicado: (2019)

Effect of Repeat Dosing of Engineered Oncolytic Herpes Simplex Virus on Preclinical Models of Rhabdomyosarcoma()
por: Waters, Alicia M., et al.
Publicado: (2016)

Triptolide inhibits cell proliferation and tumorigenicity of human neuroblastoma cells
por: YAN, XIAOMIN, et al.
Publicado: (2015)

Whole exome sequencing identified sixty-five coding mutations in four neuroblastoma tumors
por: Miller, Aubrey L., et al.
Publicado: (2017)

PIM kinases mediate resistance to cisplatin chemotherapy in hepatoblastoma
por: Marayati, Raoud, et al.
Publicado: (2021)

Rapamycin inhibits proliferation and induces autophagy in human neuroblastoma cells
por: Lin, Xiaokun, et al.
Publicado: (2018)

The Evolution of Risk Classification for Neuroblastoma
por: Sokol, Elizabeth, et al.
Publicado: (2019)

The proneural transcription factor ASCL1 regulates cell proliferation and primes for differentiation in neuroblastoma
por: Parkinson, Lydia M., et al.
Publicado: (2022)

Yokukansan enhances the proliferation of B65 neuroblastoma
por: Nakatani, Yoshihiko, et al.
Publicado: (2016)

Chromogranin A regulates neuroblastoma proliferation and phenotype
por: Zhang, Dongyun, et al.
Publicado: (2019)

Apoptotic Cell Death in Neuroblastoma
por: Li, Yuanyuan, et al.
Publicado: (2013)

Leflunomide Reduces Proliferation and Induces Apoptosis in Neuroblastoma Cells In Vitro and In Vivo
por: Zhu, Shunqin, et al.
Publicado: (2013)

Downregulation of CDKL1 suppresses neuroblastoma cell proliferation, migration and invasion
por: Li, Weiyi, et al.
Publicado: (2019)

TPX2 is a prognostic marker and promotes cell proliferation in neuroblastoma
por: Koike, Yuhki, et al.
Publicado: (2022)

Dual-Specificity Phosphatases in Neuroblastoma Cell Growth and Differentiation
por: Nunes-Xavier, Caroline E., et al.
Publicado: (2019)

Neuroblastoma
por: Pearson, D.
Publicado: (1977)

Gangliosides and Neuroblastomas
por: Schengrund, Cara-Lynne
Publicado: (2020)

Functional Dissection of HOXD Cluster Genes in Regulation of Neuroblastoma Cell Proliferation and Differentiation
por: Zha, Yunhong, et al.
Publicado: (2012)

Immunotherapy in Pediatric Solid Tumors—A Systematic Review
por: Marayati, Raoud, et al.
Publicado: (2019)

Genetic Predisposition to Neuroblastoma
por: Barr, Erin K., et al.
Publicado: (2018)

Targeting MYCN and ALK in resistant and relapsing neuroblastoma
por: Tucker, Elizabeth R, et al.
Publicado: (2019)

Down-Regulation of Phosphoribosyl Pyrophosphate Synthetase 1 Inhibits Neuroblastoma Cell Proliferation
por: Li, Jifu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7s5ebi56h1dp7q4d38obj5urto